45 results found.

Dementia, or Alzheimer's Disease Clinical Trial using [18F]NAV4694

Navidea Biopharmaceuticals - Recruiting 21 years or older.
- A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology.
[18F]NAV4694

Down Syndrome Clinical Trial using ELND005; Placebo

Elan Pharmaceuticals - Recruiting 18 years to 45 years.
- A 4-Week Randomized, Double-Blind, Placebo-Controlled, Phase 2a Safety and PK Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia.
ELND005; Placebo

Alzheimer's Disease Clinical Trial using ITI-007; Placebo

Intra-Cellular Therapies, Inc. - Recruiting 65 years or older.
- A Randomized, Double-blind, Placebo-controlled, Multiple Oral Dose Escalation for Safety, Tolerability and Pharmacokinetics of ITI-007 in Healthy Geriatric Volunteers and in Geriatric Patients With Dementia..
ITI-007; Placebo

Frontotemporal Lobar Degeneration, or Dementia Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 35 years or older.
- PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in Neurological Disorders.

Dementia Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- The Genetic Characterization of Dementia.

Adaptation Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Challenges of Living With Frontotemporal Dementia: The Perspective of the Affected Individual.

Amyotrophic Lateral Sclerosis Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Natural History and Biomarkers of C9ORF72 Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.

Dementia, Malnutrition, Depression, Pain, or Quality of Life Clinical Trial using Empowerment; Conversation with nurse

Herlev Hospital - Recruiting 65 years or older.
- Cross-sectorial Patient Participation in Prevention of Loss of Functions in Older Short-stay Medical Patients.
Empowerment; Conversation with nurse

Alzheimer's Type Dementia Clinical Trial using E2020

Eisai Inc. - Recruiting 50 years or older.
- Randomized, Multicenter, Double-blind, Double-dummy, Parallel-Group Study With an Open-label Extension Phase to Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease.
E2020

Frontotemporal Dementia, or Alzheimer's Disease Clinical Trial

Norwegian Centre for Ageing and Health - Recruiting N/A to 69 years.
- A Nordic Multicentre Observational Study of Persons With Young Onset Dementia and Their Families - Factors Influencing Quality of Life, Theirs Specific Needs and the Use of Healthcare Resources.

Alzheimer's Disease, or Dementia Clinical Trial using Drug: EVP-6124; Placebo

EnVivo Pharmaceuticals, Inc. - Recruiting 55 years to 85 years.
- A Randomized, Double-blind, Placebo-controlled, Parallel-Group, 26-Week, Phase 3 Study of 2 Doses of EVP-6124 or Placebo in Subjects With Mild to Moderate Alzheimer's Disease Currently or Previously Receiving an Acetylcholinesterase Inhibitor Medication.
Drug: EVP-6124; Placebo

Memory Loss, Memory Deficits, or Dementia Clinical Trial using Memtrax Memory screening test

Stanford University - Recruiting 55 years or older.
- Screening for Memory Studies.
Memtrax Memory screening test

Alzheimer's Disease, or Dementia Clinical Trial using Drug: EVP-6124; Placebo

EnVivo Pharmaceuticals, Inc. - Recruiting 55 years to 85 years.
- A Randomized, Double-blind, Placebo-controlled, Parallel-Group, 26-Week, Phase 3 Study of 2 Doses of EVP-6124 or Placebo in Subjects With Mild to Moderate Alzheimer's Disease Currently or Previously Receiving an Acetylcholinesterase Inhibitor Medication.
Drug: EVP-6124; Placebo

Impaired Cognition Clinical Trial using physical activity

Fundacion para la Investigacion y Formacion en Ciencias de la Salud - Recruiting 18 years or older.
- Physical Activity Program for Patients With Dementia and Their Relative Caregivers. Randomized Clinical Trial in Primary Health Care. APISDEMyF.
physical activity

Dementia, or Family Caregiver Clinical Trial using DeREACH-program

University of Leipzig - Recruiting N/A or older.
- German Adaptation of Resources to Enhance Alzheimer`s Caregiver Health.
DeREACH-program

Dementia Clinical Trial using High intensity aerobic training; Sedentary Control

Mayo Clinic - Recruiting 18 years to 80 years.
- Effect of Aging and Aerobic Exercise Training on Brain Glucose Metabolism.
High intensity aerobic training; Sedentary Control

Dementia Clinical Trial using Living with Hope Program; Stories of the Present

University of Alberta - Recruiting 18 years or older.
- Living With Hope: Pilot Study of the Living With Hope Program for Family Caregivers of Persons With Dementia Residing in Long Term Care Facilities.
Living with Hope Program; Stories of the Present

Alzheimer's Disease, or Dementia Clinical Trial using Cholinesterase Inhibitor; Placebo

Sunnybrook Health Sciences Centre - Recruiting 55 years or older.
- A Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease in Long Term Care Setting.
Cholinesterase Inhibitor; Placebo

Alzheimers Disease, Dementia, or Alzheimers Disease, Familial Clinical Trial using Gantenerumab; Solanezumab; Matching Placebo (Gantenerumab); Matching Placebo (Solanezumab)

Washington University School of Medicine - Recruiting 18 years to 80 years.
- A Phase II/III Randomized, Double-Blind, Placebo-Controlled Multi-Center Study of 2 Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease.
Gantenerumab; Solanezumab; Matching Placebo (Gantenerumab); Matching Placebo (Solanezumab)

Delirium,, Dementia,, Amnestic,, or Cognitive Disorders Clinical Trial using Sevoflurane; Propofol

Nanjing Medical University - Recruiting 10 years to 80 years.
- Long-term Outcome Followed-up of the Cognitive Disorders After General Anesthesia.
Sevoflurane; Propofol

Alzheimer Disease, Mild Cognitive Impairment, or Delirium, Dement Clinical Trial using Donepezil

New York State Psychiatric Institute - Recruiting 55 years to 95 years.
- Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly.
Donepezil

Dementia Clinical Trial using Tailored Activity Program

Department of Veterans Affairs - Recruiting 18 years or older.
- Nonpharmacologic Management of Challenging Behaviors in Veterans With Dementia.
Tailored Activity Program

Delirium, or Dementia Clinical Trial using Cognitive Stimulation

Penn State University - Recruiting 65 years or older.
- Reserve For Delirium Superimposed On Dementia (DSD).
Cognitive Stimulation

Alzheimer's Disease, or Dementia Clinical Trial

Banner Health - Recruiting 18 years or older.
- Alzheimer's Prevention Registry.

Dementia Clinical Trial using Animal-assisted activity; Animal-assisted therapy

Norwegian University of Life Sciences - Recruiting 65 years or older.
- Animal-assisted Interventions in Health Promotion for Elderly With Dementia; Impact on Factors Related to Risk of Falls.
Animal-assisted activity; Animal-assisted therapy

Dementia Clinical Trial using Animal-assisted activity; Robot-assisted activity

Norwegian University of Life Sciences - Recruiting 65 years or older.
- Animal-assisted or Robot-assisted Interventions in Health Promotion for Elderly With Dementia: Impact on Factors Related to the Risk of Falls, on Evidence Based Practice and on the Relatives' Burden.
Animal-assisted activity; Robot-assisted activity

Dementia With Lewy Bodies Clinical Trial using Electrical stimulation of the nucleus basalis of Meynert

University Hospital, Rouen - Recruiting 18 years to 75 years.
- Effects of Nucleus Basalis of Meynert Area Electrical Stimulation on Cognitive Behavioral Disorders in Dementia With Lewy Bodies : A Pilot Phase 1 Study.
Electrical stimulation of the nucleus basalis of Meynert

Dementia Clinical Trial using Day care for patients with dementia

Norwegian Centre for Ageing and Health - Recruiting 65 years or older.
- Effects and Costs of a Day Care Centre Program Designed for People With Dementia - a 24 Month Controlled Study.
Day care for patients with dementia

Alzheimer's Disease, or Dementia Clinical Trial using Drug: NIC5-15; Placebo

James J. Peters Veterans Affairs Medical Center - Recruiting 40 years to 95 years.
- A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease.
Drug: NIC5-15; Placebo

Neurodegenerative Diseases, or Dementia Clinical Trial

Sykehuset Innlandet HF - Recruiting N/A or older.
- Resource Use and Disease Course in Dementia (REDIC).

Mild Cognitive Impairment Clinical Trial using Simvastatin; Placebo

Charite University, Berlin, Germany - Recruiting 55 years to 90 years.
- Randomized Controlled Trial of Simvastatin in Amnestic MCI Patients.
Simvastatin; Placebo

Cognitive Impairment Clinical Trial using Dual task gait training; Aerobic exercise class

Parkwood Hospital, London, Ontario - Recruiting 60 years to 85 years.
- Study of Community Based and Institutional Dual Task and Aerobic Exercise Intervention on Cognition and Mobility in Older Adults With Cognitive Impairment-no Dementia.
Dual task gait training; Aerobic exercise class

Alzheimer Disease, Late Onset Alzheimer Disease, or Dementia Clinical Trial

Indiana University - Recruiting N/A or older.
- Alzheimer's Disease Genetics Study.

HIV Dementia Clinical Trial using Atorvastatin (generic Lipitor); placebo

University of Pennsylvania - Recruiting 18 years to 60 years.
- .
Atorvastatin (generic Lipitor); placebo

Memory Disorders, Alzheimer Disease, Dementia, Cognitive Impairme Clinical Trial using COGNISIONT System

Neuronetrix, Inc. - Recruiting 60 years to 90 years.
- Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISIONT) as a Useful Cognitive Biomarker for Alzheimer's Disease..
COGNISIONT System

Brain Ischemia, Adverse Effect of Thrombolytic Drugs, Impaired Co Clinical Trial

University Hospital, Lille - Recruiting 18 years or older.
- Influence of the Pre-existing Cognitive Status on the Outcome in Patients Treated by Thrombolytic Therapy for Acute Cerebral Ischaemia.

Alzheimer Disease, Dementia, Brain Diseases, Central Nervous Syst Clinical Trial using NEUROSTEMr-AD

Samsung Medical Center - Recruiting 50 years to 75 years.
- The Long-Term Safety and Efficacy Follow-up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostemr-AD.
NEUROSTEMr-AD

Alzheimers Disease, or Mild Cognitive Impairment Clinical Trial

Roskilde County Hospital - Recruiting 50 years to 90 years.
- Quantitative Electroencephalography, Cerebrospinal Fluid Biomarkers, Linear CT Analyses and Timed Up and GO Dual Task as Diagnostic Tools in Dementia and Their Ability to Predict Disease Progression..

Alzheimer Disease, Stroke, Parkinson's Disease, Lewy Body Dementi Clinical Trial using Computerized tests and Electrophysiological measurements

Centre Hospitalier Universitaire, Amiens - Recruiting 18 years to 85 years.
- Assessment of Social-emotional Functioning in Stroke, Frontotemporal Dementia, Alzheimer and Parkinson Diseases.
Computerized tests and Electrophysiological measurements

Parkinson's Disease Clinical Trial

Washington University School of Medicine - Recruiting 40 years to 70 years.
- Connecting the Lab to Everyday Life: The Relevance of Executive Dysfunction to Participation and Quality of Life in PD Without Dementia.

Frontotemporal Lobar Degeneration Clinical Trial using Tolcapone

Columbia University - Recruiting 40 years to 85 years.
- Investigation of the Dopamine System in Frontotemporal Dementia.
Tolcapone

Dementia of the Alzheimer Type Clinical Trial using StaCog, stage specific cognitive Intervention; booklet based training

University of Rostock - Recruiting 55 years or older.
- Effect of the Stage Specific Cognitive Intervention Program on Functional Cortical Activation in Alzheimer's Disease.
StaCog, stage specific cognitive Intervention; booklet based training

Alzheimer's Disease, Dementia, or Neurodegenerative Disorders Clinical Trial using Blood sampling, skin biopsy

Institut National de la Sant‚ Et de la Recherche M‚dicale, France - Recruiting 18 years to 90 years.
- Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment.
Blood sampling, skin biopsy

Progressive Supranuclear Palsy, or Dementia Clinical Trial using rivastigmine

University Hospital Tuebingen - Recruiting 50 years or older.
- Rivastigmine (Exelonr) for Treatment of Dementia in Patient With Progressive Supranuclear Paresis Open Label Phase 2 Study.
rivastigmine

Anesthesia Recovery Period, Delirium, Dementia, Cognitive Disorde Clinical Trial using Hypnotics: propofol, sevoflurane, desflurane,desflurane,midazolam

University of Roma La Sapienza - Recruiting 18 years or older.
- Post Operative Cognitive Recovery and Neuropsychological Complications After General Anesthesia. A Comparison Between Different Techniques of Anesthesia: A Multi-Center Observational Study.
Hypnotics: propofol, sevoflurane, desflurane,desflurane,midazolam